Create an Account - Increase your productivity, customize your experience, and engage in information you care about.
Show All Answers
1. Visit the Northeast Health District website and fill out a registration form: https://bit.ly/NEHDCOVIDVaccine
2. Call the Northeast Health District vaccine scheduling hotline at 706-340-0996
On December 11, 2020, Pfizer was given Emergency Use Authorization (EUA) for its COVID-19 vaccine, and the Moderna vaccine was given EUA December 18, 2020.
There are large clinical trials currently in progress or being planned for other COVID-19 vaccines in the United States.
No. You cannot make an appointment by calling or visiting a health department in the Northeast Health District.
You can make an appointment in two ways:
2. Call the Northeast Health District vaccine scheduling hotline at 706-340-0996.
Due to the limited availability at the beginning of distribution – a priority list has been established by several federal agencies.
Georgia is currently in Phase 1-A of our rollout which includes Health Care Workers (HCW) and residents and staff of Long-Term Care Facilities. Beginning January 11, 2021, the following groups will become eligible for vaccination as part of Phase 1-A:
Vaccine providers with available vaccine should vaccinate members of the community meeting any of the above criteria, not just those within their own staff or facility. However, unless they are in one of the above populations, spouses and family members are not eligible for vaccine administration at this time.
Those people may pre-register here.
Safety is a key concern among health officials and experts. Before the FDA approves a vaccine, the manufacturer must do rigorous research and testing to ensure the vaccine’s safety and effectiveness. The FDA independently reviews and verifies the information from these tests. It then decides whether the vaccine can be licensed and given to the public.
No major safety concerns were uncovered in the FDA’s review of Pfizer’s COVID-19 vaccine.
For each vaccine authorized by the FDA, the Advisory Committee on Immunization Practices (ACIP) carefully reviews all available data about the vaccine from clinical trials and other studies, and makes recommendations for vaccine use in the general public. Recommendations include groups that should and should not receive the vaccine, as well as the timing, volume, number, and spacing of doses in a vaccine series.
The FDA and CDC continue to closely monitor vaccine safety after the public begins using the vaccine. Both agencies have longstanding and new safety systems in place for heightened monitoring of all COVID-19 vaccines.
No. The COVID-19 vaccine does not contain the live virus that causes COVID-19 and cannot cause COVID-19.
Both the Pfizer and Moderna vaccines require two doses.
The Pfizer COVID-19 vaccine is administered intramuscularly (into the muscle, just like a flu shot) as a series of two doses, three weeks apart. The Moderna vaccine is also given intramuscularly as a series of two doses, 28 days apart.
Both doses are needed to get the most protection the vaccine has to offer against COVID-19.
It is recommend that individuals receive both doses of the vaccine to ensure full protection.
It is recommended individuals who have had and recovered from COVID-19 also should be vaccinated.
Private physicians and healthcare workers (dentists, pharmacists, etc.) should pursue vaccination one of three ways.
Healthcare workers with potential for direct and indirect exposure should seek out vaccination options as soon as possible.